Michael Ben Moshe

Vice President Finance, Corporate Treasury Teva Pharmaceuticals

Michael is the Vice President and Head of Global Working Capital & Cash Leadership Office at Teva Pharmaceutical Industries, the world's largest generic drug manufacturer. Bringing extensive expertise from the Pharmaceutical and Capital Markets industries, Michael plays a crucial role in overseeing Corporate Treasury activities at Teva. In his previous positions, he was leading Teva's Global Treasury Operations.

With a career spanning over 19 years, Michael has demonstrated leadership by guiding award-winning teams in implementing cutting-edge corporate finance and treasury methodologies. His diverse responsibilities include managing cash and liquidity, optimizing working capital, and mitigating financial risks within the treasury domain.

Throughout his career, Michael has successfully navigated complex tasks such as managing banking relationships, facilitating funding for major M&A transactions, optimizing the balance sheet, and executing asset divestitures. He has also played a key role in financing public offerings and spearheaded the optimization of internal cross-organizational processes to improve working capital efficiencies, fortify cash flow forecasting, and ensure liquidity.

Given Teva's intricate global operations, spanning 60 countries and involving 50 currencies, Michael's leadership within the Treasury team is instrumental in shaping and executing Teva's comprehensive financial strategy.